Ji-Won Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ji-Won Hwang has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Jae-Jin Kwak
Division of Cardiology, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
6 shared publications - Kyu-Yong Ko
Division of Cardiology, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
6 shared publications - Sung Eun Kim
Division of Cardiology, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
5 shared publications - Sung Woo Cho
Division of Cardiology, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
5 shared publications - Iksung Cho
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea
4 shared publications - Geu-Ru Hong
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Springer Nature in Journal of Cardiovascular Imaging
- Vol. 34 (1) , 35
Left ventricular diastolic dysfunction as a mediator between the CHA2DS2-VASc score and left atrial strain
The CHA₂DS₂-VASc score, originally developed for stroke risk stratification in atrial fibrillation, comprises cardiovascular risk factors that promote left ventricular (LV) diastolic dysfunction and left atrial (LA) remodeling. In this issue, Mahmoud et al. examined the association between the CHA₂DS₂-VASc score and LA function assessed by speckle-tracking echocardiography in 150 patients in sinus rhythm. LA reservoir and conduit strain decreased progressively with increasing risk category, whereas LA volume index did not differ significantly, indicating that functional impairment preceded overt LA enlargement. Using mediation analysis, the authors showed that the association with conduit strain was largely mediated by LV diastolic dysfunction, whereas reservoir strain retained a smaller direct association, suggesting an intrinsic atrial component consistent with atrial cardiomyopathy. This commentary discusses these findings within the framework of atrial remodeling and contemporary echocardiographic assessment, considers the study's principal limitations, and highlights the need for longitudinal studies to determine the prognostic significance of subclinical LA dysfunction in patients without atrial fibrillation.
- 17 September 2026
- Published by Springer Nature in Journal of Cardiovascular Imaging
- Vol. 34 (1) , 35
Open AccessLeft ventricular diastolic dysfunction as a mediator between the CHA2DS2-VASc score and left atrial strain
The CHA₂DS₂-VASc score, originally developed for stroke risk stratification in atrial fibrillation, comprises cardiovascular risk factors that promote left ventricular (LV) diastolic dysfunction and left atrial (LA) remodeling. In this issue, Mahmoud et al. examined the association between the CHA₂DS₂-VASc score and LA function assessed by speckle-tracking echocardiography in 150 patients in sinus rhythm. LA reservoir and conduit strain decreased progressively with increasing risk category, whereas LA volume index did not differ significantly, indicating that functional impairment preceded overt LA enlargement. Using mediation analysis, the authors showed that the association with conduit strain was largely mediated by LV diastolic dysfunction, whereas reservoir strain retained a smaller direct association, suggesting an intrinsic atrial component consistent with atrial cardiomyopathy. This commentary discusses these findings within the framework of atrial remodeling and contemporary echocardiographic assessment, considers the study's principal limitations, and highlights the need for longitudinal studies to determine the prognostic significance of subclinical LA dysfunction in patients without atrial fibrillation.
- Open Access
- 26 June 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (6) , 50417
Pericardial Diseases in Cardiovascular Medicine: Contemporary Diagnosis, Risk Stratification, Multimodality Imaging, and Targeted Anti-Inflammatory Therapy
Pericardial diseases comprise a heterogeneous spectrum, ranging from self-limited acute pericarditis to recurrent inflammatory syndromes, large pericardial effusions, cardiac tamponade, and chronic constrictive pericarditis. Although acute pericarditis is often considered a benign condition, a substantial proportion of patients develop recurrent or persistent disease with prolonged symptoms and an impaired quality of life. Diagnostic uncertainty and suboptimal early management, particularly excessive corticosteroid use, may further contribute to the development of chronic disease and treatment resistance. Recent advances in cardiovascular imaging and anti-inflammatory therapy have substantially transformed the management of pericardial diseases. Multimodality imaging, including echocardiography, cardiac computed tomography (CT), and cardiac magnetic resonance (CMR) imaging, plays a central role in anatomical assessment, evaluation of hemodynamic impact, and differentiation of active inflammation from irreversible fibrotic remodeling. Meanwhile, an improved understanding of the autoinflammatory pathways involved in recurrent pericarditis has led to the development of targeted therapies, most notably interleukin -1 (IL-1) inhibitors, which have demonstrated robust efficacy and meaningful steroid-sparing effects in refractory disease. This review summarizes contemporary diagnostic and therapeutic strategies for pericardial diseases, with an emphasis on recurrent pericarditis and imaging-guided management. We propose a stepwise, precision-based approach that integrates clinical risk stratification, multimodality imaging, and targeted anti-inflammatory therapy to optimize patient outcomes.
- 26 June 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (6) , 50417
Open AccessPericardial Diseases in Cardiovascular Medicine: Contemporary Diagnosis, Risk Stratification, Multimodality Imaging, and Targeted Anti-Inflammatory Therapy
Pericardial diseases comprise a heterogeneous spectrum, ranging from self-limited acute pericarditis to recurrent inflammatory syndromes, large pericardial effusions, cardiac tamponade, and chronic constrictive pericarditis. Although acute pericarditis is often considered a benign condition, a substantial proportion of patients develop recurrent or persistent disease with prolonged symptoms and an impaired quality of life. Diagnostic uncertainty and suboptimal early management, particularly excessive corticosteroid use, may further contribute to the development of chronic disease and treatment resistance. Recent advances in cardiovascular imaging and anti-inflammatory therapy have substantially transformed the management of pericardial diseases. Multimodality imaging, including echocardiography, cardiac computed tomography (CT), and cardiac magnetic resonance (CMR) imaging, plays a central role in anatomical assessment, evaluation of hemodynamic impact, and differentiation of active inflammation from irreversible fibrotic remodeling. Meanwhile, an improved understanding of the autoinflammatory pathways involved in recurrent pericarditis has led to the development of targeted therapies, most notably interleukin -1 (IL-1) inhibitors, which have demonstrated robust efficacy and meaningful steroid-sparing effects in refractory disease. This review summarizes contemporary diagnostic and therapeutic strategies for pericardial diseases, with an emphasis on recurrent pericarditis and imaging-guided management. We propose a stepwise, precision-based approach that integrates clinical risk stratification, multimodality imaging, and targeted anti-inflammatory therapy to optimize patient outcomes.
- Open Access
- 24 January 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (1)
Diagnosis and management of Brugada Syndrome Unmasked by Flecainide challenge in a patient with unexplained ventricular fibrillation: a case report
Introduction: Brugada syndrome is a genetic disorder associated with sudden cardiac death (SCD) due to ventricular fibrillation (VF). The diagnosis relies on detecting a Type 1 ST-segment elevation in the right precordial leads, which often requires sodium channel blocker provocation for confirmation. Patient concerns: We present a case of a 55-year-old male bus driver who experienced out-of-hospital cardiac arrest due to VF. Diagnosis: After resuscitation, initial evaluations, including echocardiography and cardiac enzyme tests, were normal, showing no structural heart disease. The initial electrocardiogram displayed a Type 2 Brugada pattern. Intervention: A flecainide challenge test using oral flecainide (300 mg) revealed a Type 1 Brugada pattern, confirming Brugada syndrome. Outcomes: Despite mild hypokalemia, an implantable cardioverter defibrillator (ICD) was implanted due to the patient’s high-risk occupation and VF history. Conclusion: This case underscores the importance of considering Brugada syndrome in unexplained VF cases and highlights the role of flecainide testing in diagnosis. A multidisciplinary approach, including thorough evaluation, timely ICD implantation, and patient education, is crucial for optimal outcomes, particularly for those in safety-critical professions. Recognizing Brugada syndrome and applying appropriate diagnostic and therapeutic measures are essential for preventing fatal arrhythmic events. Learning points:
- 24 January 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (1)
Open AccessDiagnosis and management of Brugada Syndrome Unmasked by Flecainide challenge in a patient with unexplained ventricular fibrillation: a case report
Introduction: Brugada syndrome is a genetic disorder associated with sudden cardiac death (SCD) due to ventricular fibrillation (VF). The diagnosis relies on detecting a Type 1 ST-segment elevation in the right precordial leads, which often requires sodium channel blocker provocation for confirmation. Patient concerns: We present a case of a 55-year-old male bus driver who experienced out-of-hospital cardiac arrest due to VF. Diagnosis: After resuscitation, initial evaluations, including echocardiography and cardiac enzyme tests, were normal, showing no structural heart disease. The initial electrocardiogram displayed a Type 2 Brugada pattern. Intervention: A flecainide challenge test using oral flecainide (300 mg) revealed a Type 1 Brugada pattern, confirming Brugada syndrome. Outcomes: Despite mild hypokalemia, an implantable cardioverter defibrillator (ICD) was implanted due to the patient’s high-risk occupation and VF history. Conclusion: This case underscores the importance of considering Brugada syndrome in unexplained VF cases and highlights the role of flecainide testing in diagnosis. A multidisciplinary approach, including thorough evaluation, timely ICD implantation, and patient education, is crucial for optimal outcomes, particularly for those in safety-critical professions. Recognizing Brugada syndrome and applying appropriate diagnostic and therapeutic measures are essential for preventing fatal arrhythmic events. Learning points:
- Open Access
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (2) , 87-95
Prognosis of Infective Endocarditis According to Clinical Characteristics, Economic Status, and Center Experience
Kim WD, et al. Yonsei Med J. 2025 Dec;66:e114. https://doi.org/10.3349/ymj.2025.0122
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (2) , 87-95
Open AccessPrognosis of Infective Endocarditis According to Clinical Characteristics, Economic Status, and Center Experience
Kim WD, et al. Yonsei Med J. 2025 Dec;66:e114. https://doi.org/10.3349/ymj.2025.0122
- Open Access
- 20 June 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (10) , 102876
Procedural and clinical risk factors of infective endocarditis – A nationwide case-control study in South Korea
- 20 June 2025
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 18 (10) , 102876
Open AccessProcedural and clinical risk factors of infective endocarditis – A nationwide case-control study in South Korea
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (31) , e183
Trends in Epidemiology, Clinical Characteristics, and Outcomes of Infective Endocarditis: A 16-Year Nationwide Cohort Study in Korea
Ha KE, et al. J Korean Med Sci. 2025 Jun;40:e183. https://doi.org/10.3346/jkms.2025.40.e183
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (31) , e183
Open AccessTrends in Epidemiology, Clinical Characteristics, and Outcomes of Infective Endocarditis: A 16-Year Nationwide Cohort Study in Korea
Ha KE, et al. J Korean Med Sci. 2025 Jun;40:e183. https://doi.org/10.3346/jkms.2025.40.e183
- Open Access
- 1 January 2025
- Published by XMLink in Cardiovascular Imaging Asia
- Vol. 9 (2) , 15-18
Post-Cardiac Injury Syndrome in End Stage Renal Disease Hemodialysis Patient After Percutaneous Coronary Intervention for Non-ST Elevated Myocardial Infarction
Kim T, et al. Cardiovasc Imaging Asia. 2025 Apr;9(2):15-18. https://doi.org/10.22468/cvia.2024.00136
- 1 January 2025
- Published by XMLink in Cardiovascular Imaging Asia
- Vol. 9 (2) , 15-18
Open AccessPost-Cardiac Injury Syndrome in End Stage Renal Disease Hemodialysis Patient After Percutaneous Coronary Intervention for Non-ST Elevated Myocardial Infarction
Kim T, et al. Cardiovasc Imaging Asia. 2025 Apr;9(2):15-18. https://doi.org/10.22468/cvia.2024.00136
- Open Access
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (1) , 1-8
Predisposing Risk Factors Affecting Reversibility of Left Ventricular Diastolic Filling Pattern in Patients with Preserved Ejection Fraction
Kim DG, et al. Yonsei Med J. 2025 Jan;66(1):1-8. https://doi.org/10.3349/ymj.2023.0410
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (1) , 1-8
Open AccessPredisposing Risk Factors Affecting Reversibility of Left Ventricular Diastolic Filling Pattern in Patients with Preserved Ejection Fraction
Kim DG, et al. Yonsei Med J. 2025 Jan;66(1):1-8. https://doi.org/10.3349/ymj.2023.0410
- Open Access
- 26 November 2024
- Published by Springer Nature in Journal of Cardiovascular Imaging
- Vol. 32 (1) , 1-2
The impact of regional impairment of longitudinal strain and regurgitant jet in aortic regurgitation on myocardial mechanics and postoperative recovery
- 26 November 2024
- Published by Springer Nature in Journal of Cardiovascular Imaging
- Vol. 32 (1) , 1-2
Open AccessThe impact of regional impairment of longitudinal strain and regurgitant jet in aortic regurgitation on myocardial mechanics and postoperative recovery
- Open Access
- 17 September 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (10) , ytae500
Rheumatic heart disease manifesting as mitral stenosis and tricuspid regurgitation in a young Asian male: a case report
Background: Rheumatic heart disease (RHD) is a major global health issue because of its potential to cause heart failure. While RHD has been reported more frequently in women, this case report highlights the clinical manifestations, diagnosis, and management of rheumatic multivalvular disease in a young Asian male. Case summary: A 46-year-old Asian man with a history of percutaneous mitral valvuloplasty (PMV) was admitted with dyspnoea and generalized oedema that severely hindered his quality of life. Transthoracic and transoesophageal echocardiography revealed severe mitral stenosis, left atrial appendage (LAA) thrombus, and severe tricuspid regurgitation due to RHD. Following a comprehensive evaluation by a multidisciplinary team, we advised mitral valve replacement, LAA thrombectomy, and tricuspid valve annuloplasty based on the detailed imaging of the valve anatomy and the patient’s low surgical risk. Surgical intervention led to considerable improvement in the patient’s symptoms, enabling a return to routine activities. Discussion: This case highlights the chronic nature of RHD and its potential to cause heart failure. This report emphasizes the need for regular follow-up in patients with a history of RHD to detect potential complications and ensure timely management. The successful outcome in this case underscores the importance of a team-based approach for managing complex valvular heart disease.
- 17 September 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (10) , ytae500
Open AccessRheumatic heart disease manifesting as mitral stenosis and tricuspid regurgitation in a young Asian male: a case report
Background: Rheumatic heart disease (RHD) is a major global health issue because of its potential to cause heart failure. While RHD has been reported more frequently in women, this case report highlights the clinical manifestations, diagnosis, and management of rheumatic multivalvular disease in a young Asian male. Case summary: A 46-year-old Asian man with a history of percutaneous mitral valvuloplasty (PMV) was admitted with dyspnoea and generalized oedema that severely hindered his quality of life. Transthoracic and transoesophageal echocardiography revealed severe mitral stenosis, left atrial appendage (LAA) thrombus, and severe tricuspid regurgitation due to RHD. Following a comprehensive evaluation by a multidisciplinary team, we advised mitral valve replacement, LAA thrombectomy, and tricuspid valve annuloplasty based on the detailed imaging of the valve anatomy and the patient’s low surgical risk. Surgical intervention led to considerable improvement in the patient’s symptoms, enabling a return to routine activities. Discussion: This case highlights the chronic nature of RHD and its potential to cause heart failure. This report emphasizes the need for regular follow-up in patients with a history of RHD to detect potential complications and ensure timely management. The successful outcome in this case underscores the importance of a team-based approach for managing complex valvular heart disease.